Inventor · disambiguated record
Shirish A. Shah
Also filed as: SHAH SHIRISH A
16 granted patents·6 pending applications·644 citations·filing 1996–2024
94Inventor score
Top patents by PatentIndex Score
22 records- 0195US11813231B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2021·Granted Nov 14, 2023·5 cites·20 claims
- 0295US11628150B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2020·Granted Apr 18, 2023·5 cites·30 claims
- 0394US6126969AImmediate release/sustained release compressed tabletsPERRIGO L CO·Filed 1997·Granted Oct 3, 2000·183 cites·7 claims
- 0494US5773031AAcetaminophen sustained-release formulationPERRIGO L CO·Filed 1996·Granted Jun 30, 1998·170 cites·7 claims
- 0592US5824338ACaplet and gelatin covering thereforPERRIGO L CO·Filed 1996·Granted Oct 20, 1998·122 cites·13 claims
- 0688US9675585B1Extended release pharmaceutical formulationsEzra Pharma·Filed 2016·Granted Jun 13, 2017·6 cites·25 claims
- 0787US11020361B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2018·Granted Jun 1, 2021·5 cites·17 claims
- 0881US5895663APseudoephedrine hydrochloride extended-release tabletsPERRIGO L CO·Filed 1997·Granted Apr 20, 1999·71 cites·45 claims
- 0980US8334281B2Nasal formulations of metoclopramideD ONOFRIO MATTHEW J·Filed 2009·Granted Dec 18, 2012·8 cites·29 claims
- 1080US2025228803A1Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2024·Application pending·0 cites
- 1177US12194009B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2021·Granted Jan 14, 2025·0 cites·14 claims
- 1277US12194008B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2021·Granted Jan 14, 2025·0 cites·17 claims
- 1372US6113945AMulti-colored medicamentPERRIGO L CO·Filed 1996·Granted Sep 5, 2000·38 cites·17 claims
- 1471US7341742B2Simethicone containing tablet composition and methodPERRIGO L CO·Filed 2002·Granted Mar 11, 2008·3 cites·30 claims
- 1565US6270807B1Taste-masked pharmaceutical compositionPERRIGO L CO·Filed 1999·Granted Aug 7, 2001·28 cites·20 claims
- 1663US2017071885A1Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2016·Application pending·0 cites
- 1757US10010529B2Extended release pharmaceutical formulations with controlled impurity levelsEZRA PHARMA LLC·Filed 2017·Granted Jul 3, 2018·0 cites·11 claims
- 1852US9687475B1Extended release pharmaceutical formulations with controlled impurity levelsEZRA PHARMA LLC·Filed 2016·Granted Jun 27, 2017·0 cites·5 claims
- 1951US2017273946A1Extended release pharmaceutical formulationsEZRA PHARMA LLC·Filed 2017·Application pending·0 cites
- 2049US2013213393A1Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2012·Application pending·0 cites
- 2137US2017326066A1Method of treating hypertensionEZRA PHARMA LLC·Filed 2016·Application pending·0 cites
- 2237US2017326065A1Methods and composition for treatment of cardiovascular conditionsEZRA PHARMA LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shirish A. Shah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →